142
views
0
recommends
+1 Recommend
1 collections
    8
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Late-Onset Aspergillus Fumigatus Infection of an Aortic Stent Graft in an Immunocompetent Patient

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Aspergillus fumigatus as a clinical entity is difficult to diagnose. We present a case, which could facilitate diagnosis and management of the aforementioned disease. A 60-year-old man with stent graft implantation in the descending aorta (6 years ago) presented with fever, night sweats, and weight loss over 5 months. Leukocytosis and elevated C-reactive protein were constantly spiking. Blood cultures were negative. Notably, the serum immunoglobulin E (IgE) level was strongly elevated (> 1,000 U/mL). Anamnestically, the patient suffered from a mild form of atopic dermatitis and bronchial asthma. The pulmonary status showed no abnormalities in the computed tomography image. Nonetheless, a chest scan revealed a suspected abscess around the stent graft of the descending aorta. Extra-anatomic ascending to descending aortic bypass (Gelsoft 22 mm, Vascutek, Juchinnan, Scotland, United Kingdom) was performed. Intraoperative samples revealed A. fumigatus. These findings were confirmed by polymerase chain reaction analysis. Infection by A. fumigatus represents a diagnostic challenge because blood cultures are usually negative, but expeditious treatment is required to prevent occurrence of irreversible complications. A late graft infection, possibly caused by A. fumigatus should be suspected in patients with implanted grafts, who suffer from unexplained, blood culture-negative fever that does not respond to antibiotics and who have a history of dermatitis or bronchial asthma with elevated IgE antibodies.

          Most cited references5

          • Record: found
          • Abstract: found
          • Article: not found

          Pathogenesis of Aspergillus fumigatus in Invasive Aspergillosis.

          Aspergillus species are globally ubiquitous saprophytes found in a variety of ecological niches. Almost 200 species of aspergilli have been identified, less than 20 of which are known to cause human disease. Among them, Aspergillus fumigatus is the most prevalent and is largely responsible for the increased incidence of invasive aspergillosis (IA) in the immunocompromised patient population. IA is a devastating illness, with mortality rates in some patient groups reaching as high as 90%. Studies identifying and assessing the roles of specific factors of A. fumigatus that contribute to the pathogenesis of IA have traditionally focused on single-gene deletion and mutant characterization. In combination with recent large-scale approaches analyzing global fungal responses to distinct environmental or host conditions, these studies have identified many factors that contribute to the overall pathogenic potential of A. fumigatus. Here, we provide an overview of the significant findings regarding A. fumigatus pathogenesis as it pertains to invasive disease.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            New insights into atopic dermatitis.

            Atopic dermatitis is a chronic inflammatory skin disease associated with cutaneous hyperreactivity to environmental triggers and is often the first step in the atopic march that results in asthma and allergic rhinitis. The clinical phenotype that characterizes atopic dermatitis is the product of interactions between susceptibility genes, the environment, defective skin barrier function, and immunologic responses. This review summarizes recent progress in our understanding of the pathophysiology of atopic dermatitis and the implications for new management strategies.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Pulmonary aspergillosis: a clinical update.

              Aspergillus spp may cause a variety of pulmonary diseases, depending on immune status and the presence of underlying lung disease. These manifestations range from invasive pulmonary aspergillosis in severely immunocompromised patients, to chronic necrotizing aspergillosis in patients with chronic lung disease and/or mildly compromised immune systems. Aspergilloma is mainly seen in patients with cavitary lung disease, while allergic bronchopulmonary aspergillosis is described in patients with hypersensitivity to Aspergillus antigens. Recent major advances in the diagnosis and management of pulmonary aspergillosis include the introduction of non-invasive tests, and the development of new antifungal agents, such as azoles and echinocandins, that significantly affect the management and outcome of patients with pulmonary aspergillosis. This review provides a clinical update on the epidemiology, risk factors, clinical presentation, diagnosis and management of the major syndromes associated with pulmonary aspergillosis.
                Bookmark

                Author and article information

                Journal
                Thorac Cardiovasc Surg Rep
                Thorac Cardiovasc Surg Rep
                10.1055/s-00024355
                The Thoracic and Cardiovascular Surgeon Reports
                Georg Thieme Verlag KG (Stuttgart · New York )
                2194-7635
                2194-7643
                10 July 2015
                December 2015
                : 4
                : 1
                : 56-58
                Affiliations
                [1 ]Department of Cardiac Surgery, Friedrich-Alexander University, Erlangen-Nuremberg, Germany
                [2 ]Department of Vascular Surgery, Friedrich-Alexander University, Erlangen-Nuremberg, Germany
                [3 ]Institute of Clinical Microbiology, Immunology and Hygiene, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany
                Author notes
                Address for correspondence Dr med. Univ. Fatos Ballazhi Department of Cardiac Surgery Universitätsklinikum Erlangen Krankenhausstrasse 12, Erlangen 91054Germany fatos.ballazhi@ 123456uk-erlangen.de
                Article
                150150crv
                10.1055/s-0035-1555013
                4670309
                a6a18d82-3582-4a15-a8a8-07a3ddf725d0
                © Thieme Medical Publishers
                History
                : 12 January 2015
                : 28 April 2015
                Categories
                Article

                graft infection,aorta,aspergillus fumigatus
                graft infection, aorta, aspergillus fumigatus

                Comments

                Comment on this article